News Sentiment

PLUR sentiment intelligence

Pluri Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 49 Balanced news tone 45 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.72 Week of 10 Jul 2026
Weighted tone 49/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

76/100 classification confidence.

Company focus 36

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-18.7% over one week, -24.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Pluri chairman raises stake above 30%; shares up

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 76/100 classification
One-week reaction -18.7% Price reacting lower
Trend fit Trend inactive -24.4% over four weeks
Fair value -63.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 31
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 36
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 9
Market source 8
TradingKey 7
Stock Titan 5
Finviz 2
dars.gov.et 2
simplywall.st 2
MSN 1

Event Lens

What the news is about

Classified themes
Earnings 21
Market update 20
Deals and strategy 2
Regulatory and legal 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 45
MSN Direct company coverage

Pluri chairman raises stake above 30%; shares up

Pluri's chairman, Zami Aberman, has increased his stake in the company to over 30%, reflecting strong confidence in the biotech firm without triggering a mandatory tender offer. This significant acquisition led to an almost 10% rise in Pluri's shares. The company is actively deve

Tone
Positive 89/100
Event
Deals and strategy
Published
15 Jul 2026 00:11
Source
MSN
Stock Titan Direct company coverage

Pluri Chairman Builds 30%-Plus Position With $17M Investment

Pluri Inc. announced that Chairman Alejandro Weinstein has invested over $17 million in the company during the past year, increasing his ownership to more than 30%. This significant investment includes a $1.25 million advance made in June 2026, coinciding with Pluri's strategic s

Tone
Positive 88/100
Event
Market update
Published
14 Jul 2026 11:10
Source
Stock Titan
Market source Direct company coverage

Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%

Pluri Inc. Chairman Alejandro Weinstein has increased his investment in the company to over $17 million, resulting in an ownership stake exceeding 30%. This significant commitment comes as Pluri transitions its focus towards commercialization, particularly in the longevity sector

Tone
Positive 73/100
Event
Deals and strategy
Published
14 Jul 2026 11:10
Source
Market source
TradingView Direct company coverage

Pluri Disclosed Failure to Satisfy a Continued Listing Rule or Standard

Pluri Inc. (PLUR) received a notice from Nasdaq on July 7, 2026, indicating non-compliance with Listing Rule 5550(b)(2) due to failing to maintain a market value of listed securities of at least $35 million or meet alternative equity or net income standards. The company has 180 d

Tone
Negative 18/100
Event
Market update
Published
13 Jul 2026 20:13
Source
TradingView
Stock Titan Direct company coverage

Pluri (PLUR) director Doron Shorrer files Form 3 listing share holdings

Pluri Inc. director Doron Shorrer has filed a Form 3, disclosing his beneficial ownership of the company's common stock. The filing indicates direct ownership of 6,659 shares and indirect ownership of 6,969 shares through Shorrer International Ltd. This initial statement is requi

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 20:10
Source
Stock Titan
Finviz Direct company coverage

PLUR - Pluri Inc Latest SEC Filings

This article provides the latest SEC filings and comprehensive financial data for Pluri Inc. (PLUR). It includes key metrics such as market capitalization, income, sales, earnings per share, insider ownership, and various performance indicators. The data offers an overview of the

Tone
Neutral 50/100
Event
Earnings
Published
04 Jul 2026 05:40
Source
Finviz
Investing.com UK Direct company coverage

Form 13D/A Pluri Inc. For: 1 July By Investing.com

This article from Investing.com announces the filing of Form 13D/A by Pluri Inc. for July 1st. It serves as a brief financial markets update, indicating a specific regulatory filing by the company. The text predominantly features navigation, advertisements, and market data rather

Tone
Neutral 50/100
Event
Regulatory and legal
Published
01 Jul 2026 21:06
Source
Investing.com UK
Stock Titan Direct company coverage

Pluri (NASDAQ: PLUR) director logs RSU grant as 625,000 warrants expire

Pluri Inc. director Alexandre Weinstein reported receiving 641 shares of common stock as an RSU grant, increasing his directly held shares to 6,925. Separately, 625,000 common warrants held indirectly through Chutzpah Holdings LP, with an exercise price of $4.25 per share, expire

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 19:39
Source
Stock Titan
Stock Titan Direct company coverage

[SCHEDULE 13D/A] Pluri Inc. Amended Major Shareholder Report

This amended Schedule 13D/A filing for Pluri Inc. details the updated beneficial ownership of major shareholder Alexandre Weinstein and his affiliated entities (Chutzpah Holdings Ltd., Chutzpah Holdings LP, and Plantae Bioscience Ltd.). As of June 30, 2026, the group beneficially

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 19:39
Source
Stock Titan
TradingView Direct company coverage

Price to sales forward of Pluri Inc. – NASDAQ:PLUR

This article provides financial data for Pluri Inc. (NASDAQ: PLUR), specifically focusing on its price-to-sales forward ratio. The content appears to be a snapshot from a financial platform like TradingView, showing an overview of the company's financials without detailed analysi

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 09:10
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Pluri Inc. – NASDAQ:PLUR

This article provides a financial overview of Pluri Inc. (NASDAQ: PLUR), focusing on its enterprise value to EBITDA forward metric. The content is primarily a data page from TradingView, displaying key financial information for the biotechnology company. It categorizes PLUR withi

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 17:09
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Pluri Inc. – NASDAQ:PLUR

The article provides a brief overview of Pluri Inc. (NASDAQ: PLUR), focusing on its price to earnings forward metric. It appears to be an excerpt from a financial data platform, showing the company's stock market information and some underlying data sources.

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 05:10
Source
TradingView
TradingView Direct company coverage

Pluri Inc. Actuals & Estimates (NASDAQ:PLUR)

This article provides financial actuals and estimates for Pluri Inc. (NASDAQ:PLUR), including its current stock price, historical highs and lows, market capitalization, volatility, and upcoming earnings date. It also covers the company's net income, employee count, EBITDA, and te

Tone
Negative 29/100
Event
Earnings
Published
26 Jun 2026 14:10
Source
TradingView
TradingView Direct company coverage

Pluri Inc. Actuals & Estimates (FWB:4DX)

This article provides financial actuals and estimates for Pluri Inc. (FWB:4DX), covering income statement, balance sheet, and cash flow data, as well as valuation metrics. It includes frequently asked questions about the company's stock ticker, historical prices, earnings reports

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 06:09
Source
TradingView
TradingView Direct company coverage

Pluri Inc. Actuals & Estimates (TASE:PLUR)

This article provides an overview of Pluri Inc. (TASE:PLUR) stock, including its current price, historical performance, market capitalization, and financial estimates. It highlights recent stock price changes, upcoming earnings reports, and key financial metrics like net income a

Tone
Negative 38/100
Event
Earnings
Published
25 Jun 2026 20:40
Source
TradingView
TradingKey Direct company coverage

Pluri Inc (PLUR) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Pluri Inc (PLUR), indicating a current risk score of 2.15, ranking it 235 out of 387 in the Biotechnology & Medical Research industry. Key metrics include a beta value of 0.66, suggesting lower volatility compared to the S&P 500, a 240-

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 02:09
Source
TradingKey
Stock Titan Direct company coverage

Pluri (NASDAQ: PLUR) gets $1,250,000 insider advance and appoints new director

Pluri Inc. (NASDAQ: PLUR) received a $1,250,000 advance from Chutzpah Holdings LP, an entity beneficially owned by the company's chairman, to be used for working capital and general corporate purposes, with the expectation that it will be credited against securities purchased in

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 19:39
Source
Stock Titan
TradingKey Direct company coverage

Pluri Inc (PLUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Pluri Inc (PLUR), detailing its price momentum, support and resistance levels, and various technical indicators and moving averages. The stock is currently trading between support at $1.81 and resistance at $2.42, with indicators and

Tone
Negative 35/100
Event
Market update
Published
22 Jun 2026 15:40
Source
TradingKey
TradingKey Direct company coverage

Pluri Inc (PLUR) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Pluri Inc (PLUR), highlighting that no earnings forecast score is currently available, but the industry average is 8.15. Analysts project a price target of $12.00 for PLUR, with expected revenue of $655.00K for the next quarter. The

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 23:10
Source
TradingKey
TradingKey Direct company coverage

Pluri Inc (PLUR) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Pluri Inc (PLUR), highlighting its current valuation score of 8.50 within the Biotechnology & Medical Research industry, ranking 124 out of 389. The company's P/E ratio is noted at -0.69, which is below its recent high and above its r

Tone
Negative 34/100
Event
Market update
Published
18 Jun 2026 23:10
Source
TradingKey
TradingKey Direct company coverage

Pluri Inc (PLUR) Institutional Confidence

The article analyzes the institutional confidence score for Pluri Inc (PLUR), which currently stands at 3.00, ranking it 193 out of 389 in the Biotechnology & Medical Research industry. The institutional shareholding proportion has decreased by 14.97% quarter-over-quarter to 12.5

Tone
Negative 42/100
Event
Market update
Published
18 Jun 2026 11:39
Source
TradingKey
TradingKey Direct company coverage

Pluri Inc (PLUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article displays the revenue breakdown for Pluri Inc (PLUR) but notes that relevant data regarding business segments, regional revenue, and profit contribution has not yet been disclosed by the company. It serves primarily as a placeholder or an indication that this informat

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 04:39
Source
TradingKey
TradingKey Direct company coverage

Pluri Inc (PLUR) Financial Health: Profitability & Balance Sheet Analysis

Pluri Inc (PLUR) has a weak financial status with a score of 5.30, ranking low within the Biotechnology & Medical Research industry. The company reported a significant year-over-year decrease in revenue by 60.89% to $167.00K, alongside a 9.74% decrease in net profit. Its operatio

Tone
Negative 19/100
Event
Earnings
Published
18 Jun 2026 00:39
Source
TradingKey
TradingView Direct company coverage

PLUR Stock Price and Chart — NASDAQ:PLUR

This article provides a detailed overview of Pluri Inc. (NASDAQ:PLUR) stock, including its current price, historical performance, earnings information, and key financial stats. It also offers technical analysis summaries, lists ETFs holding the stock, and answers frequently asked

Tone
Neutral 50/100
Event
Earnings
Published
11 Jun 2026 08:39
Source
TradingView
Moomoo Direct company coverage

Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing

Pluri's subsidiary Cellav has completed the listing of its regenerative aesthetic products with the FDA, moving closer to a commercial launch in the U.S. This development enables Cellav to market its products in the U.S. and represents a significant step for Pluri in expanding it

Tone
Neutral 50/100
Event
Market update
Published
05 Jun 2026 20:09
Source
Moomoo
Finviz Direct company coverage

PLUR - Pluri Inc Stock Price and Quote

This article provides detailed stock information for Pluri Inc. (PLUR), including its current stock price, financial metrics, performance indicators, and a comprehensive list of recent company news and announcements. It highlights the company's activities in biotechnology, cell t

Tone
Neutral 50/100
Event
Market update
Published
05 Jun 2026 05:41
Source
Finviz
Investing.com Canada Direct company coverage

Pluri subsidiary completes U.S. cosmetic listing for two products By Investing.com

Pluri Inc.'s subsidiary, Cellav Health and Aesthetics Ltd., has completed U.S. cosmetic product listings for two regenerative aesthetic products, Regenativo+ and Placento+. These products, designed for topical professional use, are based on plant-derived and placenta-derived form

Tone
Neutral 50/100
Event
Market update
Published
04 Jun 2026 01:10
Source
Investing.com Canada